Bullboard - Stock Discussion Forum Curaleaf Holdings Inc T.CURA

Alternate Symbol(s): CURLF

Healthcare Cannabis

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including... see more

Add To Watchlist

TSX:CURA - Post Discussion

Curaleaf Holdings Inc > Curaleaf Holdings to release Q1 results May 17

View:

Post by blackspade799 on May 16, 2023 5:42pm

Curaleaf Holdings to release Q1 results May 17

CURALEAF TO REPORT FIRST QUARTER 2023 FINANCIAL AND OPERATIONAL RESULTS

Curaleaf Holdings Inc. will release its financial and operating results for the first quarter ended March 31, 2023, after market close on May 17, 2023.

Management will host a conference call and audio webcast that afternoon at 5 p.m. ET, consisting of prepared remarks followed by a question-and-answer session related to the company's operational and financial highlights.

Event: Curaleaf first quarter 2023 financial results conference call

Date: Wednesday, May 17, 2023

Time: 5 p.m. ET

Live call: 1-844-512-2926 (United States), 1-416-639-5883 (Canada) or 1-412-317-6300 (international)

Passcode: 5395830

Webcast: on the Curaleaf website

For interested individuals unable to join the conference call, a dial-in replay of the call will be available until May 24, 2023, and can be accessed by dialling 1-877-344-7529 (United States), 1-855-669-9658 (Canada) or 1-412-317-0088 (international) and entering replay PIN (personal identification number) 2106379.

About Curaleaf Holdings Inc.

210

Comment

Comment by TheProphetElijah on May 17, 2023 1:55pm

AYR must have put out a good Q since the share price seems to think so. Hopefully CURA is next.

Comment

Comment by blackspade799 on May 17, 2023 6:05pm

Excellent Q1 numbers Curaleaf Reports Q1-2023 Results $336.5M Revs; est. $332.7M $73.2M AEBITDA; est. $71.3M CURA Beat Rev and AEBITA Good JOB!! LOOKING GOOD FOR Q2 Q3 Q4 Germany is going to be a big player!!

169

Comment

Comment by Bullknit101 on May 18, 2023 8:14am

Exceeded expectations. We just need some reform.

Comment

Comment by TheProphetElijah on May 18, 2023 9:59am

Still not profitable though, $50m net loss

Comment

Comment by blackspade799 on May 18, 2023 11:21am

With greater savings on opex and capex with automation, building out our Portugal facility and signing a lucrative deal with a Canadian private producer to help accommodate Germans medical roll out, we are entering a new growth stage which should greatly materalize in Late Q3-Q4. With more product roll outs in our mature markets, CURA will continue its growth even with a recession incoming. I am ...more

105

Comment